Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

KRYS

Krystal Biotech (KRYS)

Krystal Biotech Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KRYS
DateTimeSourceHeadlineSymbolCompany
06/07/20245:09PMPR Newswire (US)KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600NASDAQ:KRYSKrystal Biotech Inc
06/05/20246:00AMGlobeNewswire Inc.Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:KRYSKrystal Biotech Inc
05/21/20243:38PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRYSKrystal Biotech Inc
05/15/20246:00AMGlobeNewswire Inc.Krystal Biotech to Present at the American Thoracic Society 2024 International ConferenceNASDAQ:KRYSKrystal Biotech Inc
05/08/20246:00AMGlobeNewswire Inc.Krystal Biotech to Present at BofA Securities 2024 Health Care ConferenceNASDAQ:KRYSKrystal Biotech Inc
05/06/20247:17AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KRYSKrystal Biotech Inc
05/06/20247:09AMIH Market NewsIndex Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices RiseNASDAQ:KRYSKrystal Biotech Inc
05/06/20247:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRYSKrystal Biotech Inc
05/06/20247:00AMGlobeNewswire Inc.Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:KRYSKrystal Biotech Inc
05/02/20246:00AMGlobeNewswire Inc.Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual MeetingNASDAQ:KRYSKrystal Biotech Inc
04/26/20246:00AMGlobeNewswire Inc.Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024NASDAQ:KRYSKrystal Biotech Inc
04/22/20246:00AMGlobeNewswire Inc.Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the LungNASDAQ:KRYSKrystal Biotech Inc
04/04/20246:00AMGlobeNewswire Inc.Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual MeetingNASDAQ:KRYSKrystal Biotech Inc
03/01/20247:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRYSKrystal Biotech Inc
03/01/20247:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRYSKrystal Biotech Inc
02/28/20248:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRYSKrystal Biotech Inc
02/28/20246:00AMGlobeNewswire Inc.Krystal Biotech to Present at TD Cowen 44th Annual Health Care ConferenceNASDAQ:KRYSKrystal Biotech Inc
02/26/202412:35PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRYSKrystal Biotech Inc
02/26/20247:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRYSKrystal Biotech Inc
02/26/20247:00AMGlobeNewswire Inc.Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdatesNASDAQ:KRYSKrystal Biotech Inc
02/26/20246:59AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KRYSKrystal Biotech Inc
02/26/20246:49AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:KRYSKrystal Biotech Inc
02/26/20244:57AMIH Market NewsU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil and Iron Ore Prices RetreatNASDAQ:KRYSKrystal Biotech Inc
02/20/20246:00AMGlobeNewswire Inc.Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024NASDAQ:KRYSKrystal Biotech Inc
02/13/20246:00AMGlobeNewswire Inc.Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the LungNASDAQ:KRYSKrystal Biotech Inc
02/08/20246:00AMGlobeNewswire Inc.Krystal Biotech Announces Publication in the New England Journal of Medicine on the Application of B-VEC to Treat Ocular Complications in Patient with Dystrophic Epidermolysis BullosaNASDAQ:KRYSKrystal Biotech Inc
02/01/20246:00AMGlobeNewswire Inc.Krystal Biotech to Present at Guggenheim 6th Annual Biotechnology ConferenceNASDAQ:KRYSKrystal Biotech Inc
01/24/20244:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRYSKrystal Biotech Inc
01/22/202410:43AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRYSKrystal Biotech Inc
01/04/20246:00AMGlobeNewswire Inc.Krystal Biotech Receives Permanent J-code (J3401) for VYJUVEK®NASDAQ:KRYSKrystal Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:KRYS

Your Recent History

Delayed Upgrade Clock